Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution
Open Access
Abstract
Pseudomonas aeruginosa is a major opportunistic pathogen with high levels of antibiotic resistance. Phage therapy represents a promising alternative for the treatment of difficult infections both alone and in combination with antibiotics. Here, we isolated and characterized three novel lytic myoviruses, Cisa, Nello, and Moonstruck. Genomic analysis revealed that Cisa and Nello belong to the Pbunavirus genus, while Moonstruck is a novel Pakpunavirus species. All lacked lysogeny, virulence, or resistance-associated genes, supporting their therapeutic suitability. Phage Nello and Moonstruck were active against P. aeruginosa Pa3GrPv, isolated from a patient with lung infection candidate for phage therapy. Moonstruck exhibited superior lytic activity with ciprofloxacin sub-MIC value (0.125 µg/mL), achieving bacterial suppression for 48 h. However, to improve the lytic efficacy of the phages on the clinical isolate, phage adaptation via serial passage was investigated. The killing efficacy of Nello was enhanced, whereas Moonstruck showed a less consistent improvement, suggesting phage-specific differences in evolutionary dynamics. Sequencing of the evolved phages revealed point mutations in tail-associated genes, potentially linked to a better phage–host interaction. These results support the use of phage–antibiotic combinations and directed evolution as strategies to enhance phage efficacy against drug-resistant infections. Overall, these findings support the therapeutic potential of the newly isolated phages in treating P. aeruginosa lung infections.Keywords
Funding Information
- Italian Ministry of Health (I53C22001300001, I53C22000780001)
- PNRR THE e Tuscany Health Ecosystem (I53C22001300001, I53C22000780001)
This publication has 64 references indexed in Scilit:
- Isolation and characterization of novel Staphylococcus aureus bacteriophage Hesat from dairy originApplied Microbiology and Biotechnology, 2024
- High-resolution cryo-EM structure of the Pseudomonas bacteriophage E217Nature Communications, 2023
- Characterization of a novel phage vB_Pae_HB2107-3I that infects Pseudomonas aeruginosaMolecular Genetics and Genomics, 2023
- Phage therapy: From biological mechanisms to future directionsCell, 2023
- Characterization of the newly isolated Pseudomonas phage vB_Pae_LC3I3Virus Research, 2022
- Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniaeNature Communications, 2022
- Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?Clinical Therapeutics, 2020
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategiesBiotechnology Advances, 2019
- Pseudomonas Bacteriophage Isolation and Production2014
- A system for the continuous directed evolution of biomoleculesNature, 2011